Showing results (341-350 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|June 15, 2022
Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and SafetySimona Lattanzi, Eugen Trinka, Claudia Altamura, et al.
Neurology and Therapy|June 15, 2022
Outcomes of Endovascular Therapy in Young Patients with Acute Basilar Artery Occlusion: A Substudy of BASILAR Registry StudyJinrong Hu, Xing Liu, Shuai Liu, et al.
Neurology and Therapy|July 31, 2021
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes SurveyJuan González-Moreno, Inés Losada-López, Eugenia Cisneros-Barroso, et al.
Neurology and Therapy|May 5, 2022
Assessing the Clinical Meaningfulness of the Alzheimer's Disease Composite Score (ADCOMS) ToolAmir Abbas Tahami Monfared, William R Lenderking, Yulia Savva, et al.
Neurology and Therapy|May 28, 2022
Functional Specificity of TPS Brain Stimulation Effects in Patients with Alzheimer's Disease: A Follow-up fMRI AnalysisGregor Dörl, Eva Matt, Roland Beisteiner
Neurology and Therapy|May 24, 2022
A Narrative Review on Axonal Neuroprotection in Multiple SclerosisNicolas Collongues, Guillaume Becker, Valérie Jolivel, et al.
Neurology and Therapy|May 13, 2022
COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional StudyVenja Musche, Alexander Bäuerle, Lisa Jahre, et al.
Neurology and Therapy|December 9, 2022
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model PredictionsJaime K Devine, Lindsay Schwartz, Steven Hursh, et al.
Neurology and Therapy|January 29, 2021
Quantifying Knowledge of Alzheimer's Disease: An Analysis of the Psychometric Properties of the Alzheimer's Disease Knowledge ScaleGuillermo Garcia-Ribas, Elena García-Arcelay, Alonso Montoya, et al.
Neurology and Therapy|December 7, 2016
Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 TrialTakahiko Saida, Jun-Ichi Kira, Shuji Kishida, et al.
Pageof 95